share_log

Mirum Pharmaceuticals(MIRM.US)获Stifel首次覆盖,给予买入评级, 目标价48.00美元。

Zhitong Finance ·  Apr 17 07:25

Mirum Pharmaceuticals(MIRM.US)获Stifel首次覆盖,给予买入评级, 目标价48.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment